2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression
作者:David S. Carter、Hai-Ying Cai、Eun Kyung Lee、Pravin S. Iyer、Matthew C. Lucas、Ralf Roetz、Ryan C. Schoenfeld、Robert J. Weikert
DOI:10.1016/j.bmcl.2010.05.008
日期:2010.7
Recently a class of compounds known as triple reuptake inhibitors has emerged as a new strategy for the treatment of depression. These compounds work by simultaneously inhibiting the synaptic reuptake of serotonin, norepinephrine and dopamine. In this Letter we describe the optimization of a novel series of 2-substituted N-aryl piperazine based triple reuptake inhibitors. (c) 2010 Elsevier Ltd. All rights reserved.
3-ALKYL-PIPERAZINE DERIVATIVES AND USES THEREOF
申请人:F. Hoffmann-La Roche AG
公开号:EP2254884B1
公开(公告)日:2013-05-01
US7998963B2
申请人:——
公开号:US7998963B2
公开(公告)日:2011-08-16
[EN] 3-ALKYL-PIPERAZINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE 3-ALKYL-PIPÉRAZINE ET LEURS UTILISATIONS
申请人:HOFFMANN LA ROCHE
公开号:WO2009101018A2
公开(公告)日:2009-08-20
Compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein Ar, R1, R2, R3 and R4 are as defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.